![Visible genomics](/api/images/company-pic/0-2268185-company.png)
Contate-nos
Sobre companhia
Visible Genomics provides a clinically validated age-related macular degeneration (AMD) risk assessment. The company's comprehensive risk assessment provide advanced awareness of disease risk which will empower the patient and healthcare professional to make informed clinical and lifestyle decisions together, help slow or prevent disease, and provide greater access to more patients through affordable, easy, and understandable genetic risk testing.
US
Desconhecido
Empresa não verificada
Transparência de negócios
- Não verificou as informações da empresa
- Peça avaliações aos seus clientes
- Não respondeu a comentários negativos